Literature DB >> 8640762

Impaired proliferation and tumorigenicity induced by CCAAT/enhancer-binding protein.

P J Watkins1, J P Condreay, B E Huber, S J Jacobs, D J Adams.   

Abstract

A plasmid containing the CCAAT/enhancer-binding protein (C/EBP alpha) gene transcriptionally controlled by the metallothionein promoter was constructed. The gene was transfected into the human hepatocellular carcinoma cell lines Hep3B and HepG2. When cultured in vitro in the presence of 100 microM ZnSO(4), C/EBP alpha expression caused reversible growth arrest. In soft agar clonogenic assays, C/EBP alpha expression decreased both the colony size and the total number of colonies compared with zinc-free controls. C/EBP alpha expressing cells s.c. implanted in CD-1 nu/nu mice were essentially nontumorigenic, whereas C/EBP alpha tumor cells implanted into immunodeficient SCID mice demonstrated a significantly delayed time of tumor appearance compared with cells transfected with a vector control plasmid. These studies suggest that the expression of endogenous genes normally associated with a quiescent, differentiated state, such as C/EBP alpha, can result in impaired proliferative activity and suppressed tumorigenicity of hepatoma cell lines.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8640762

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Maturation-dependent gene expression in a conditionally transformed liver progenitor cell line.

Authors:  A S Fiorino; A M Diehl; H Z Lin; I R Lemischka; L M Reid
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-03       Impact factor: 2.416

Review 2.  A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood.

Authors:  A R Lourenço; P J Coffer
Journal:  Oncogene       Date:  2017-05-15       Impact factor: 9.867

Review 3.  Liver enriched transcription factors and differentiation of hepatocellular carcinoma.

Authors:  Y Hayashi; W Wang; T Ninomiya; H Nagano; K Ohta; H Itoh
Journal:  Mol Pathol       Date:  1999-02

4.  C/EBPalpha inhibits cell growth via direct repression of E2F-DP-mediated transcription.

Authors:  B A Slomiany; K L D'Arigo; M M Kelly; D T Kurtz
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

Review 5.  Dysregulation of the C/EBPalpha differentiation pathway in human cancer.

Authors:  Steffen Koschmieder; Balazs Halmos; Elena Levantini; Daniel G Tenen
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

6.  Glucocorticoid-stimulated CCAAT/enhancer-binding protein alpha expression is required for steroid-induced G1 cell cycle arrest of minimal-deviation rat hepatoma cells.

Authors:  R A Ramos; Y Nishio; A C Maiyar; K E Simon; C C Ridder; Y Ge; G L Firestone
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

7.  C/EBPalpha redirects androgen receptor signaling through a unique bimodal interaction.

Authors:  J Zhang; M Gonit; M D Salazar; A Shatnawi; L Shemshedini; R Trumbly; M Ratnam
Journal:  Oncogene       Date:  2009-11-09       Impact factor: 9.867

8.  Expression and sub-cellular localization of the CCAAT/enhancer binding protein alpha in relation to postnatal development and malignancy of the prostate.

Authors:  Juan Zhang; John Erby Wilkinson; Mesfin Gonit; Rick Keck; Steven Selman; Manohar Ratnam
Journal:  Prostate       Date:  2008-08-01       Impact factor: 4.104

9.  CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors.

Authors:  H S Radomska; C S Huettner; P Zhang; T Cheng; D T Scadden; D G Tenen
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

10.  C/EBPalpha expression is partially regulated by C/EBPbeta in response to DNA damage and C/EBPalpha-deficient fibroblasts display an impaired G1 checkpoint.

Authors:  R Ranjan; E A Thompson; K Yoon; R C Smart
Journal:  Oncogene       Date:  2009-07-06       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.